Paramount-Warner Deal Turns Into a Regulatory Standoff

Jul 20 - Jul 24across 5 daysImpact

Paramount-Warner Faces Prolonged Delay

A judge first blocked Paramount’s Warner Bros. Discovery acquisition, then extended the order before Paramount agreed to pause the transaction. The outside closing date could stretch to June 2027, increasing execution costs and termination risk.

17 stories20 Mon 21 Tue 22 Wed 23 Thu 24 Fri

Jul 20 - Jul 22across 3 daysImpact

Prologis Escalates Segro Takeover

Segro rejected repeated approaches while disputing the bidder’s valuation assumptions, but Prologis ultimately raised its offer to about £14 billion and called it best and final. The contest now puts direct pressure on Segro’s board and shareholders.

5 stories20 Mon 21 Tue 22 Wed

Jul 22 - Jul 23across 2 daysImpact

Regulators Complicate Deal Timelines

The possible EU review of Apollo’s easyJet bid showed how ownership rules can narrow the buyer pool, while the Justice Department signaled a more targeted approach to merger investigations. Together, the developments point to a regulatory process that may become more focused but remains capable of disrupting transactions.

3 stories22 Wed 23 Thu

Jul 20 - Jul 26across 2 daysImpact

Private Capital Targets Large Platforms

Institutional and private-capital buyers pursued large platforms across industrial real estate, infrastructure, corporate credit, and wealth management. Competing bids and large portfolio transfers showed continued appetite for recurring fees, hard assets, and control of operating platforms.

5 stories20 Mon 21 Tue 22 Wed 23 Thu 24 Fri 26 Sun

Jul 21Impact

UK Takeover Wave Gathers Force

UK-listed companies attracted more than $60 billion in takeover value after OCS agreed to buy Mitie, reinforcing concern that public companies are becoming targets for private capital. The broader use of bear-hug tactics added pressure to the UK market’s contested-deal environment.

3 stories21 Tue

Jul 23 - Jul 24across 2 daysImpact

Stripe Pursues OpenRouter

Stripe’s potential acquisition of OpenRouter appeared on successive days at a valuation near $10 billion, with terms still unsettled. The deal would extend Stripe from payments into AI infrastructure and distribution.

2 stories23 Thu 24 Fri

Jul 21Impact

Pharma Drives Biotech Deal Surge

Drugmakers pushed biotech dealmaking to record levels as patent expirations created pressure to replace blockbuster medicines. Buyers concentrated on late-stage assets and platforms capable of supporting multiple products.

1 story21 Tue

Week’s Recap

Stories that evolved over the week.